A multicenter phase II trial of bi-weekly irinotecan (CPT11), infusional 5-fluorouracil (5FU) and leucovorin (LV) with oral tegafur/uracil (UFT) for metastatic colorectal cancer (MCRC)

Authors :: Toru Kono
S. Kasai
Y. Yamamoto
I. Tomita
T. Asama
Naoyuki Chisato
N. Kawabata
M. Ihara
K. Kamiya
Source :: Journal of Clinical Oncology. 22:3666-3666
Publication Year :: 2004
Publisher :: American Society of Clinical Oncology (ASCO), 2004.
Abstract: 3666 Background: : CPT11 combined with continuous infusional 5FU has shown to be an effective and tolerable regimen in MCRC.UFT enhanced plasma 5FU concentration and anti-tumor effects during 5FU i...

Subjects :: Cancer Research
medicine.medical_specialty
Colorectal cancer
business.industry
Tegafur/uracil
medicine.disease
Gastroenterology
digestive system diseases
Irinotecan
Regimen
Oncology
Fluorouracil
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools